Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trial of Two-Dose Standard Measles Vaccination Schedule
NCT00168662Phase 4Completed
- Sponsor
- Bandim Health Project
- Start
- Mar 1995
- Primary completion
- Jan 2006
- Modality
- Live Attenuated Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
Phase 4, randomised trial of measles virus vaccine live in measles (2 arms), sponsored by Bandim Health Project. Primary endpoints: Vaccination coverage, Vaccine efficacy and 2 more. Started Mar 1995; status: completed.
02
Drugs
measles virus vaccine live
03
Conditions
measles
Beyond the preview
Go deeper on NCT00168662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00168662.